SCHIZOPHRENIA:WHAT ARE THE BEST TREATMENT OPTIONS - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

SCHIZOPHRENIA:WHAT ARE THE BEST TREATMENT OPTIONS

Description:

Negative:Withdrawl,Lack of Volition,Poverty of Thought,Diff. with Abstract Thinking,Anhedonia. ... Key worker for the critical period. Assessment of needs ... – PowerPoint PPT presentation

Number of Views:83
Avg rating:3.0/5.0
Slides: 10
Provided by: gau87
Category:

less

Transcript and Presenter's Notes

Title: SCHIZOPHRENIA:WHAT ARE THE BEST TREATMENT OPTIONS


1
SCHIZOPHRENIAWHAT ARE THE BEST TREATMENT OPTIONS
?
  • GAUTAM KHANNA
  • ANCRUM MEDICAL CENTRE
  • 26/09/06

2
  • Prevalence of 0.2-0.7
  • 20 recover fully
  • Symptoms
  • PositiveDelusions,Hallucinations,Thought
    Disorder
  • NegativeWithdrawl,Lack of Volition,Poverty of
    Thought,Diff. with Abstract Thinking,Anhedonia.
  • Aff.SymptomsUnstable Mood,Depression,Irritable
  • Con.SymptomsImpaired attention,Inform.
    Process.,verbal fluency,Inability to shift
    construct

3
Early Intervention
  • Early detection and assessment
  • Key worker for the critical period
  • Assessment of needs
  • Atypical antipsychotics cognative therapy.
  • Involvement of Family/Friends
  • Relapse prev. treatment resistance.
  • Basic needs to be met.
  • Ass. t/t of co-morbidity.

4
COGNATIVE BEHAVIOURAL THERAPY.
  • Recommended by NICE.
  • CBT-effective early on.
  • Improves general wellbeing.
  • -ve cochrane review.
  • reduced hospital stay,improved mental state
  • No adv. after 1 year.

5
CONVENTIONAL ATYPICAL ANTIPSYCHOTICS
  • SIDE EFFECTS
  • Akathesiarestless legs,inability to sit
    still-onset within few days.
  • Dystoniaacute within hrs or chronic over months
    or years.
  • Parkinsonismusually within several weeks.
  • Tardive dyskinesiaoften takes years.

6
CLOZAPINE TREATMENT RESISTANCE
  • Incidence of neutropenia and agranulocytosis
  • Regular monitoring is mandatory
  • Weight gainDiabetes/cardiac problem
  • Sedation
  • Salivation

7
Do atypicals treat mood dysfunction and negative
symptoms
  • Basis of claim-high 5HT2/D2 binding profile of
    (Olanzapine,quetiapine and risperidone) reduced
    propensity to cause movement disorder
  • Amisulpride-selective dopamine D2/D3 antagonist.
  • Superior efficacy in treating negative symptoms
  • Fewer extrapyramidal s/e..fewer treatment
    dropouts.

8
Are atypicals effective in cognitive symptoms
  • Cognitive deficit impact on patients
    functioning-within 5 yrs less that 20 are
    working.
  • MATRICS is working towards finding best t/t for
    cognitive impairment.
  • Conventionals do not improve
  • Those with antichol. activity like CPZ may
    aggravate the problem.
  • Atypical improve cognitive impairment-tentative
    claim.

9
Is There A Role For Typical Antipsychotics?
  • NICE recommendation - atypical antipsychotics be
    used as a first choice treatment.
  • Meta-analysis of 52 randomised trials concluded
    that no evidence that atypicals were better
    tolerated than conventionalscriticised about
    the adverse effect of conv. antipsychoclozapine
    more effective than convent. followed by
    amisulpride/olanzapine/risperidone.
  • Other atypicals showed no adv.
  • Typical antipsychotics have a place for t/t pts
    who have been stable and free of s/eesp. on long
    acting depots.
Write a Comment
User Comments (0)
About PowerShow.com